Back to today’s briefing

Story perspectives

UK's NHS Launches Personalized Cancer Vaccine for 10,000

4/14/2025

49 5

Summary

NHS Expands Cancer Vaccines

The NHS is set to broaden its Cancer Vaccine Launch Pad, targeting advanced skin cancer with personalized vaccines for 10,000 patients by 2030. The promising new melanoma vaccine, iSCIB1+, boosts immune response and holds potential to thwart cancer's return. This bold move underscores the UK's dedication to pioneering cancer therapies and enhancing patient lives.

Summary

UK Approves Cancer Breakthrough

The UK has welcomed a breakthrough in breast cancer treatment as the National Institute for Health and Care Excellence (NICE) greenlights capivasertib. This innovative drug, when paired with fulvestrant, boosts progression-free survival by four months, bringing renewed hope to approximately 3,000 women each year seeking a better quality of life.

1 of 2

NHS Expands Cancer Vaccines

The NHS is set to broaden its Cancer Vaccine Launch Pad, targeting advanced skin cancer with personalized vaccines for 10,000 patients by 2030. The promising new melanoma vaccine, iSCIB1+, boosts immune response and holds potential to thwart cancer's return. This bold move underscores the UK's dedication to pioneering cancer therapies and enhancing patient lives.

1 / 2